Advertisement
Screener

Canopy Growth Corp (CGC) Deferred Income Tax Liabilities, Net

2.0 / 5 stars · 16/40 Roast Me

Canopy Growth Corp Deferred Income Tax Liabilities, Net

Canopy Growth Corp (CGC) had Deferred Income Tax Liabilities, Net of CAD 7.92 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-07

  • 2026-06-30: Deferred Income Tax Liabilities, Net 7.92M CAD.
  • 2026-03-31: Deferred Income Tax Liabilities, Net 8.20M CAD.
  • 2023-06-30: Deferred Income Tax Liabilities, Net 1.20M CAD.
  • 2023-03-31: Deferred Income Tax Liabilities, Net 357.00K CAD.
Period endDeferred Income Tax Liabilities, Net
2026-06-307.92M CAD
10-Q · filed 2026-08-07
2026-03-318.20M CAD
10-Q · filed 2026-08-07
2023-06-301.20M CAD
10-Q · filed 2023-08-09
2023-03-31357.00K CAD
10-Q · filed 2023-08-09
2022-12-318.99M CAD
10-Q · filed 2023-02-09
2022-09-309.76M CAD
10-Q · filed 2022-11-09
2022-06-3014.66M CAD
10-Q · filed 2022-08-09
2022-03-3115.99M CAD
10-K · filed 2023-06-22
2021-12-3127.37M CAD
10-Q · filed 2022-02-09
2021-09-3025.46M CAD
10-Q · filed 2021-11-08
2021-06-3026.57M CAD
10-Q · filed 2021-08-06
2021-03-3121.38M CAD
10-K · filed 2022-05-31
2020-12-3123.25M CAD
10-Q · filed 2021-02-09
2020-09-3039.57M CAD
10-Q · filed 2020-11-09
2020-06-3045.82M CAD
10-Q · filed 2020-08-10
2020-03-3147.11M CAD
10-K · filed 2021-06-01
2019-03-31105.08M CAD
10-K · filed 2020-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87